Sofiva Genomics Co.,Ltd. (TPEX:6615)
Taiwan · Delayed Price · Currency is TWD 33.95
+0.35 (1.04%)
At close: Apr 24, 2026
Sofiva Genomics Market Cap
Sofiva Genomics has a market cap or net worth of 733.1 million as of April 24, 2026. Its market cap has decreased by -15.55% in one year.
Market Cap
733.10M
Enterprise Value
644.22M
Revenue
385.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.95
Market Cap Chart
Since January 5, 2017, Sofiva Genomics's market cap has decreased from 1.70B to 733.10M, a decrease of -56.85%. That is a compound annual growth rate of -8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 733.10M | 12.60% |
| Dec 31, 2025 | 651.04M | -24.53% |
| Dec 31, 2024 | 862.66M | -1.51% |
| Dec 29, 2023 | 875.86M | 11.72% |
| Dec 30, 2022 | 784.00M | -24.75% |
| Dec 30, 2021 | 1.04B | -4.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 230.12B |
| Caliway Biopharmaceuticals | 155.17B |
| Heron Neutron Medical | 60.80B |
| Lotus Pharmaceutical | 58.87B |
| MegaPro Biomedical | 799.30M |
| Neith | 793.51M |
| Kim Forest Enterprise | 788.11M |
| AmCad BioMed | 778.99M |